Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma

Straka, Christian and Schaefer-Eckart, Kerstin and Hertenstein, Bernd and Bassermann, Florian and Salwender, Hans and Langer, Christian and Kroenke, Jan and Kull, Miriam and Schilling, Georgia and Schieferdecker, Aneta and Engelhardt, Monika and Knop, Stefan and Reusch, Julia and Roesler, Wolf and Metzner, Bernd and Hebart, Holger and Reichle, Albrecht and Grube, Matthias and Frickhofen, Norbert and Gerecke, Christian and Fuhrmann, Stephan and Jung, Wolfram and Gramatzki, Martin and Decker, Thomas and Dechow, Tobias and Greiner, Jochen and Bruemmendorf, Tim H. and Ababei, Juliana and von Metzler, Ivana and Naumann, Ralph and Fritz, Elisabeth and Hentrich, Marcus and Bojko, Peter and Kubin, Thomas and Schmidt, Christian and Kaufmann, Martin and Schmidt, Burkhard and Hinke, Axel and Einsele, Hermann (2022) Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma. In: 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), December 10-13, 2022, New Orleans, LA.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Petra Gürster
Date Deposited:	05 Sep 2023 05:45
Last Modified:	05 Sep 2023 05:45
URI:	https://pred.uni-regensburg.de/id/eprint/58690

Actions (login required)

View Item